Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis

Mayu Sun(Shanghai Jiao Tong University), Hui Wang(Beijing University of Chinese Medicine)
Journal for ImmunoTherapy of Cancer
June 1, 2021
Cited by 40


Related Papers